Botanical species · safety record

Delphinium staphisagria

The EFSA Compendium of Botanicals holds 9 constituent measurements for Delphinium staphisagria. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Delphinium staphisagria L.

9Constituent measurements
0Safety records
9Cited sources
13Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 13 licensed products naming Delphinium staphisagria as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Dried ripe seeds
  • Grain(s)
  • Seed(s)

What the records describe

Constituents measured

  • Alkaloids4
  • Diterpene alkaloids4
  • Norditerpene alkaloids1

Plant parts

  • Seed7
  • Aerial part of plants2

Preparations

  • Solvent extraction5

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsSeedSolvent extraction0.12 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
Diterpene alkaloidsSeedNuclear Magnetic Resonance (NMR)Resolve DOI
Diterpene alkaloidsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsSeedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
AlkaloidsSeedNuclear Magnetic Resonance (NMR)No resolvable identifier
AlkaloidsSeedSolvent extractionUnspecifiedNo resolvable identifier
Diterpene alkaloidsSeedNuclear Magnetic Resonance (NMR)No resolvable identifier
Diterpene alkaloidsAerial part of plantsNuclear Magnetic Resonance (NMR)No resolvable identifier
Norditerpene alkaloidsSeedSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Jacobs, Walter A., Craig, Lyman C. The aconite alkaloids. VII. Staphisine, a new alkaloid from Delphinium staphisagria. Journal of biological chemistry, 1941, p. 67-84.
  2. Liang, X., Desai, H.K., Pelletier, S.W. Two novel norditerpenoid alkaloids from Delphinium staphisagria. Journal of natural products, 1990, vol. 53, no. 5, p. 1307-1311.
  3. Pelletier, S. William., Mody, Naresh V., Djarmati, Zoltan., Lajsic, Stevan D. The structures of staphigine and staphirine. Two novel bisditerpene alkaloids from Delphinium staphisagria. Journal of organic chemistry, 1976, p. 3042-3044.
  4. PELLETIER, SW., BADAWI, MM. NEW ALKALOIDS FROM DELPHINIUM-STAPHISAGRIA. Journal of natural products, 1987, vol. 50, no. 3, p. 381-385. DOI
  5. Ulubelen, A., Meri�li, A.H., Meri�li, F., Kolak, U., Desai, H.K., Pelletier, S.W. Diterpenoid alkaloids from the aerial parts of Delphinium staphisagria L.. Scientia pharmaceutica, 1999, vol. 67, no. 3, p. 181-184.
  6. Diaz, JG., Ruiz, JG., de la Fuente, G. Alkaloids from Delphinium staphisagria. Journal of natural products, 2000, vol. 63, no. 8, p. 1136-1139. DOI
  7. De Pasquale, R.C., Controneo, A., Iauk, L., Dugo, G. Composition and biological activity of the fatty seed oil of delphinium staphisagria - note i. Pharmaceutical biology, 1985, vol. 23, no. 1, p. 5-11. DOI
  8. Pelletier, S.W., Djarmati, Z., Lajsic, S., De Camp, W.H. Alkaloids of Delphinium staphisagria. The structure and stereochemistry of delphisine, neoline, chasmanine, and homochasmanine. Journal of the american chemical society, 1976, vol. 98, no. 9, p. 2617-2625.
  9. Davidson, W. M. Insecticidal tests with oils and alkaloids of larkspur (Delphinium consolida) and stavesacre (Delphinium staphisagria). Journal of economic entomology, 1929, p. 226-234.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue